FDA Office of Review Management
Executive Summary
Center for Drug Evaluation & Research Deputy Director for Review Management Murray Lumpkin, MD, returns to his position Sept. 11 following a three month sabbatical at the European Medicines Evaluation Agency (1"The Pink Sheet" June 5, p. 8). Office of Drug Evaluation IV Director Dianne Murphy, MD, who served as acting deputy director of the review management branch, will retain her former titles, including Associate Director of Pediatrics